
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ZAR1 CRISPR/Cas9 KO Plasmid (h) | sc-406501 | 20 µg | $397.00 |
ZAR1 (zygote arrest 1) encodes an RNA-binding protein best characterized for roles in early embryogenesis, where it supports oocyte-to-zygote transition and post-transcriptional control of maternal mRNAs. In human cells, ZAR1 is linked to regulation of mRNA stability/translation and cytoplasmic ribonucleoprotein granule dynamics, processes that shape cell-cycle progression and developmental competence. Altered expression or dysregulation of maternal-effect and germline-associated RNA regulatory factors has been associated with infertility phenotypes and developmental failure in model systems, making ZAR1 relevant to studies of reproductive biology and early developmental pathways. As a maternally enriched factor, ZAR1 also provides a tractable node for investigating how RNA regulatory networks intersect with stress responses and differentiation programs.
ZAR1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the ZAR1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the ZAR1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the ZAR1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish ZAR1 protein expression.
This CRISPR knockout system enables efficient generation of ZAR1-deficient cell models for investigation of ZAR1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.